Recently, a collaborative effort among research centers in the United States and Europe resulted in the development of ...

Medical imaging and nuclear medicine are fundamental techniques used in today’s health care for diagnosing and treating diseases, with a measurable impact on saving patients’ lives. However, the globa ...

The recently released Biograph mMR is the first commercially available integrated whole-body PET/MR scanner. There are considerable advantages to integrating both modalities in a single scanner that ...

We aimed to systematically determine the impact of tumor burden on 68Ga-prostate-specific membrane antigen-11 (68Ga-PSMA) PET biodistribution by the use of quantitative measurements. Methods: This ...

Journal of Nuclear Medicine March 2025, jnumed.124.269299; DOI: https://doi.org/10.2967/jnumed.124.269299 ...

The Nuclear Medicine Global Initiative was formed in 2012 by 13 international organizations to promote human health by advancing the field of nuclear medicine and molecular imaging by supporting the ...

Theranostic strategies involve select radionuclides that allow diagnostic imaging and tailored radionuclide therapy in the same patient. An example of a Food and Drug Administration–approved ...

We took a novel approach to testing between the competing models of Aβ accumulation: we used the whole-cortex Aβ profile derived from the longitudinal study of Jack et al. (in which the patients did ...

Elevation of the end-tidal partial pressure of CO2 (PETco2) increases cerebral and myocardial blood flow (MBF), suggesting that it may be a suitable alternative to pharmacologic stress or exercise for ...

There is a significantly growing interest in diagnostic and therapeutic radiopharmaceuticals, and it is foreseeable that an unprecedented number of patients will need to be treated with new nuclear ...

Journal of Nuclear Medicine March 2025, jnumed.124.269175; DOI: https://doi.org/10.2967/jnumed.124.269175 ...

RECIST was developed in 2000 by the National Cancer Institute, European Organization for Research and Treatment of Cancer, and National Cancer Institute of Canada, with revision to RECIST 1.1 in 2009 ...